இயற்கை ஆராய்ச்சி இதழ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இயற்கை ஆராய்ச்சி இதழ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இயற்கை ஆராய்ச்சி இதழ் Today - Breaking & Trending Today

Nation-Leading COVID-19 Variant Surveillance Initiative Now Underway: Premier Medical Laboratory Services


Share this article
Share this article
GREENVILLE, S.C., April 21, 2021 /PRNewswire/  The Biden Administration announced Friday a $1.7 billion investment to monitor new and emerging COVID-19 variants which could induce another pandemic wave. Concurrently, to combat these mutated strains, advanced molecular diagnostics laboratory, Premier Medical Laboratory Services announces their launch of one of the nation s largest variant surveillance initiatives. Now conducting genomic sequencing of 6,000 specimens per day, PMLS plans to increase that number to 12,000 by May. The large amounts of data gathered by this initiative will help protect the population from a future surge and cases with increased severity of symptoms.   ....

New York , United States , United Kingdom , South Carolina , South Africa , Kevin Murdock , Vidhya Narayanan , Human Health Services , Nature Research Journal , Founder Of Premier Medical Laboratory Services , Laboratory Services , Scientific Director , Clinical Genetics , Premier Medical Laboratory , Research Journal , Medical Laboratory Services , Advanced Cardiovascular Testing , Allergen Specific Ige Blood Testing , Medical Laboratory , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , தெற்கு கரோலினா , கெவின் மர்டாக் , மனிதன் ஆரோக்கியம் சேவைகள் , இயற்கை ஆராய்ச்சி இதழ் ,

Caris Life Sciences Study Provides First Systematic Assessment of RNA Expression of Key Molecules Involved in the Infectious Process Leading to COVID-19 in Advanced Cancer


 Patients with cancer demonstrate particularly poor outcomes from COVID-19
. Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, has published results from a study that analyzed a cohort of 38,628 cancer patients to gain insight into why cancer patients have poor outcomes from COVID-19.  Investigators identified that ACE2, TMPRSS2, and other proteases that are key factors necessary for viral attachment to and entry into target cells.
Caris study results have been published in
Scientific Reports, A Nature Research Journal, finding substantial variability of expression of ACE2 and TMPRSS2 across tumor types while identifying subpopulations expressing ACE2 at very high levels. This study provides the first systematic assessment of RNA expression of key molecules involved in the infectious process, and offers a biological explanation for why cancer patients do poorly when ....

New York , United States , W Michael Korn , John Marshall , Lindsey Bailys , Caris Pharmatech , Time Clinical Trial Solutions , A Nature Research Journal , Division Hematology , Caris Life Sciences Media Contact , Georgetown University , Oncology Network , Caris Life Sciences , Department Of Medicine , Life Sciences , Scientific Reports , Nature Research Journal , Chief Medical Officer , Caris Life , Caris Artificial Intelligence , Caris Molecular Intelligence , Caris Pharmatech Just In Time , Pharmatech Just In Time Clinical Trial Solutions , Cari Just In Time Trial Matching System , Life Sciences Media Contact , புதியது யார்க் ,